Non-invasive brain stimulation for treatment-resistant schizophrenia: protocol of a systematic review and network meta-analysis.

Siafis, Spyridon; Lorenz, Carolin; Wu, Hui; Zhu, Yikang; Schneider-Thoma, Johannes; Bighelli, Irene; Li, Chunbo; Hansen, Wulf-Peter; Padberg, Frank; Salanti, Georgia; Leucht, Stefan (2024). Non-invasive brain stimulation for treatment-resistant schizophrenia: protocol of a systematic review and network meta-analysis. Systematic Reviews, 13(1), p. 165. BioMed Central 10.1186/s13643-024-02585-2

Preview	Text s13643-024-02585-2.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (1MB) | Preview
Preview	Text (PRISMA-P, Prospero, Search Strategies) Siafis_SystRev_2024_supplmat.pdf - Supplemental Material Available under License Creative Commons: Attribution (CC-BY). Download (338kB) | Preview

BACKGROUND

Non-invasive brain stimulation (NIBS) is a promising intervention for treatment-resistant schizophrenia. However, there are multiple available techniques and a comprehensive synthesis of evidence is lacking. Thus, we will conduct a systematic review and network meta-analysis to investigate the comparative efficacy and safety of NIBS techniques as an add-on to antipsychotics for treatment-resistant schizophrenia.

METHODS

We will include single- and double-blind randomized-controlled trials (RCT) comparing any NIBS technique with each other or with a control intervention as an add-on to antipsychotics in adult patients with treatment-resistant schizophrenia. We will exclude studies focusing on predominant negative symptoms, maintenance treatment, and single sessions. The primary outcome will be a change in overall symptoms, and secondary outcomes will be a change in symptom domains, cognitive performance, quality of life, functioning, response, dropouts, and side effects. We will search for eligible studies in previous reviews, multiple electronic databases and clinical trial registries from inception onwards. At least two independent reviewers will perform the study selection, data extraction, and risk of bias assessment. We will measure the treatment differences using standardized mean difference (SMD) and odds ratio (OR) for continuous and dichotomous outcomes, respectively. We will conduct pairwise and network meta-analysis within a frequentist framework using a random-effects model, except for rare event outcomes where we will use a fixed-effects Mantel-Haenszel method. We will investigate potential sources of heterogeneity in subgroup analyses. Reporting bias will be assessed with funnel plots and the Risk of Bias due to Missing Evidence in Network meta-analysis (ROB-MEN) tool. The certainty in the evidence will be evaluated using the Confidence in Network Meta-analysis (CINeMA) approach.

DISCUSSION

Our network meta-analysis would provide an up-to-date synthesis of the evidence from all available RCTs on the comparative efficacy and safety of NIBS for treatment-resistant schizophrenia. This information could guide evidence-based clinical practice and improve the outcomes of patients.

SYSTEMATIC REVIEW REGISTRATION

PROSPERO-ID CRD42023410645.

Interest & Impact

Downloads

4 since deposited on 26 Jun 2024
4 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item